The effect of cholinesterase inhibitors on the secretion of APPS from rat brain cortex

Annals of the New York Academy of Sciences

Volumn 777, Issue , 1996, Pages 393-398

  Giacobini, E ^a,b   Mori, F ^a   Lai, C C ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Institutions Univiversitaires de Geriatrie de Geneve   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETHANECHOL; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DICHLORVOS; MUSCARINIC RECEPTOR; PHYSOSTIGMINE; TETRODOTOXIN;

ALZHEIMER DISEASE; ANIMAL TISSUE; BRAIN CORTEX; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROSTIMULATION; ENZYME INHIBITION; NEUROPROTECTION; NONHUMAN; PHARMACOLOGICAL STIMULATION; PROTEIN PROCESSING; PROTEIN SECRETION; RAT;

ANIMALIA;

EID: 0029983531     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb34451.x     Document Type: Conference Paper

References (15)

1. GIACOBINI, E. & G. CUADRA. 1994. Second and third generation cholinesterase inhibitors: From preclinical studies to clinical efficacy. In Alzheimer Disease: Therapeutic Strategies. E. Giacobini & R. Becker, Eds. 155-171. Cambridge: Birkhauser Boston.
2. GIACOBINI, E. 1994. Therapy of Alzheimer disease symptomatic or neuroprotective? In Neuroprotection in Neurodegeneration. P. Riederer, J. Fritze & M. B. H. Youdim eds. Neural Transm. 43(Suppl.):211-217. New York: Springer-Verlag.
3. NITSCH, R. M., B. E. SLACK, R. J. WURTMAN & J. H. GROWDON. 1992. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304-307.
4. BUXBAUM, J. D., M. OISHI, H. I. CHEN, R. PINKAS-KRAMARSKI, E. A. JAFFE, S. E. GANDY & P. GREENGARD. 1992. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89:10075-10078.
5. NISHIZUKA, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:597-603.
6. NITSCH, R. M., S. A. FARBER, J. H. GROWDON & R. J. WURTMAN. 1993. Release of amyloid β-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. USA 90:5191-5193.
7. NITSCH, R. M. & J. H. GROWDON. 1994. Role of neurotransmission in the regulation of amyloid β-protein precursor processing. Biochem. Pharmacol. 47(8):1275-1284.
8. GIACOBINI, E. 1994. Cholinomimetic therapy of Alzheimer disease: Does it slow down deterioration? In Recent Advances in the Treatment of Neurodegenerative Disorders and Cognitive Dysfunction, Int. Acad. Biomed. Drug Res., Vol. 7. G. Racagni, N. Brunello & S. Z. Langer, eds. 51-57. Basel: Karger.
9. CUADRA, G. R., K. L. SUMMERS & E. GIACOBINI. 1994. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo. J. Pharmacol. Exp. Thera. 270(1):277-284.
10. DESARNO, P., M. POMPONI, E. GIACOBINI, X.-C. TANG & E. WILLIAMS. 1989. The effect of heptylphysostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat. Neurochem. Res. 14(10):971-977.
11. HALLAK, M. & E. GIACOBINI. 1987. A comparison of the effects of two inhibitors on brain cholinesterase. Neuropharmacology 26(6):521-530.
12. MORI, F., C.-C. LAI, F. FUSI & E. GIACOBINI. 1995. Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. NeuroReport 6(47):633-636.
13. JOHNSON, C. D. & R. L. RUSSELL. 1975. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Analyt. Biochem. 64: 229-238.
14. DEKOSKY, S. T., S. D. STYREN & M. E. O'MALLEY. 1994. Cholinergic changes and synaptic alterations in Alzheimer's disease. In Alzheimer Disease: Therapeutic Strategies. E. Giacobini & R. Becker, Eds. 93-98. Cambridge: Birkhauser Boston.
15. TERRY, R. D., E. MASLIAH, D. P. SALMON, N. BUTTERS, R. DETERESA, R. HILL, L. A. HANSEN & R. KATZMAN. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30:572-580.